Product correctly added to cart.

Paricalcitol

CAS 131918-61-1: Paricalcitol

Description:Paricalcitol is a synthetic analog of vitamin D2, primarily used in the treatment of secondary hyperparathyroidism associated with chronic kidney disease. Its chemical structure allows it to bind to vitamin D receptors, promoting calcium absorption and regulating parathyroid hormone levels. Paricalcitol is characterized by its ability to reduce parathyroid hormone secretion without significantly increasing serum calcium levels, making it a preferred option in managing hyperparathyroidism in patients with renal impairment. The substance is typically administered via injection or orally, depending on the clinical scenario. It is known for its relatively low risk of causing hypercalcemia compared to other vitamin D analogs. Paricalcitol is also recognized for its favorable pharmacokinetic profile, which includes a longer half-life and effective tissue distribution. As with any medication, monitoring for potential side effects, such as hypercalcemia or hyperphosphatemia, is essential during treatment. Overall, paricalcitol plays a crucial role in managing mineral and bone disorders in patients with chronic kidney disease.

Formula:C27H44O3

InChI:InChI=1S/C27H44O3/c1-18(8-9-19(2)26(3,4)30)24-12-13-25-21(7-6-14-27(24,25)5)11-10-20-15-22(28)17-23(29)16-20/h8-11,18-19,22-25,28-30H,6-7,12-17H2,1-5H3/b9-8+,21-11+/t18-,19+,22-,23-,24-,25+,27-/m1/s1

InChI key:InChIKey=BPKAHTKRCLCHEA-UBFJEZKGSA-N

SMILES:OC1CC(=CC=C2CCCC3(C)C2CCC3C(C=CC(C)C(O)(C)C)C)CC(O)C1

  • Synonyms:
  • (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
  • (1R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-Octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol
  • (1R,3R,7E,17beta)-17-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethylhex-2-en-1-yl]-9,10-secoestra-5,7-diene-1,3-diol
  • 1,3-Cyclohexanediol, 5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3R,5Z)-
  • 19-Nor-1,25-dihydroxyvitamin D<sub>2</sub>
  • 19-Nor-1α-25-dihydroxyvitamin D2
  • 19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol, (1α,3β,7E,22E)-
  • 1α,25-Dihydroxy-19-nor-vitamin D<sub>2</sub>
  • Zemplar
  • Paricalcitol
  • See more synonyms
Sort by


See more categories

This search does not contain any category.

Found 9 products.

discount label

Paricalcitol

CAS:131918-61-1

Ref: 45-1499403

10mg4,061.00 €
Estimated delivery in United States, on Wednesday 19 Mar 2025
discount label

Paricalcitol

CAS:131918-61-1

Ref: 7W-GX3893

Undefined sizeTo inquire
Estimated delivery in United States, on Friday 21 Mar 2025
discount label

Ref: 4Z-P-442

5mgTo inquire
10mg6,772.00 €
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Friday 21 Mar 2025
discount label

Paricalcitol

CAS:131918-61-1

Ref: 4Z-P-441

5mgTo inquire
10mgTo inquire
15mg996.00 €
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Friday 21 Mar 2025
discount label

Paricalcitol

CAS:131918-61-1

Ref: TM-TQ0200

1mg144.00 €
5mg567.00 €
10mg810.00 €
25mg1,225.00 €
50mg1,644.00 €
100mg2,232.00 €
Estimated delivery in United States, on Thursday 27 Mar 2025
discount label

Paricalcitol-d6

Controlled Product
CAS:131918-61-1

Ref: TR-P195302

1mg972.00 €
10mg7,001.00 €
25mg14,895.00 €
Estimated delivery in United States, on Tuesday 8 Apr 2025
discount label

22Z-Paricalcitol

Controlled Product
CAS:131918-61-1

Ref: TR-P195320

25mg37,343.00 €
Estimated delivery in United States, on Wednesday 30 Apr 2025
discount label

Paricalcitol

Controlled Product
CAS:131918-61-1

Ref: TR-P195300

1mg155.00 €
5mg468.00 €
25mg1,361.00 €
Estimated delivery in United States, on Wednesday 30 Apr 2025
discount label

Paricalcitol

CAS:131918-61-1

Ref: 3D-FP26765

5mg562.00 €
10mg795.00 €
25mg1,377.00 €
50mg2,176.00 €
100mg3,709.00 €
Estimated delivery in United States, on Thursday 15 May 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".